Publications (35) IGNACIO MANUEL LOZANO MARTINEZ-LUENGAS publications

2023

  1. Biventricular versus left ventricular only stimulation: an echocardiographic substudy of the B-LEFT HF trial

    Journal of Cardiovascular Medicine, Vol. 24, Núm. 7, pp. 453-460

  2. Extraction of a fractured pacemaker lead in the left bundle branch area using a snare via a femoral approach

    Journal of Interventional Cardiac Electrophysiology, Vol. 66, Núm. 2, pp. 239-240

2021

  1. Stroke prevention in patients with atrial fibrillation. Improving protection in the COVID-19 era

    Revista Espanola de Cardiologia Suplementos, Vol. 21, Núm. SA, pp. 9-17

2019

  1. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort

    European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 764-775

  2. Safety and efficacy of dronedarone from clinical trials to real-world evidence: Implications for its use in atrial fibrillation

    Europace, Vol. 21, Núm. 12, pp. 1764-1775

  3. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: A long-term randomized trial (RM-ALONE)

    European Heart Journal, Vol. 40, Núm. 23, pp. 1837-1846

  4. Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices

    Journal of Interventional Cardiac Electrophysiology, Vol. 54, Núm. 3, pp. 267-275

  5. Survival and arrhythmic risk among ischemic and non-ischemic heart failure patients with prophylactic implantable cardioverter defibrillator only therapy: A propensity score-matched analysis

    International Journal of Cardiology, Vol. 274, pp. 163-169

2018

  1. 2018 ESC Guidelines for the diagnosis and management of syncope

    European Heart Journal, Vol. 39, Núm. 21, pp. 1883-1948

  2. Implantable cardioverter-defibrillator in hypertrophic cardiomyopathy

    Global Cardiology Science and Practice

  3. Treatment of atrial fibrillation in patients with enhanced sympathetic tone by pulmonary vein isolation or pulmonary vein isolation and renal artery denervation: clinical background and study design: The ASAF trial: ablation of sympathetic atrial fibrillation

    Clinical Research in Cardiology, Vol. 107, Núm. 7, pp. 539-547

2013

  1. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation [3]

    New England Journal of Medicine

2012

  1. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?

    European Journal of Heart Failure, Vol. 14, Núm. 6, pp. 635-641

  2. Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology

    Revista Espanola de Cardiologia, Vol. 65, Núm. 10, pp. 869-873

2011

  1. Device therapy and hospital reimbursement practices across European countries: A heterogeneous scenario

    Europace, Vol. 13, Núm. SUPPL. 2

  2. Response to letter regarding article, "primary results from the smartdelay determined AV optimization: A comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: A randomized trial comparing empirical, echocardiography-guided and algorithmic atrioventricular delay programming in cardiac resynchronization therapy"

    Circulation

2010

  1. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: The Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial

    American Heart Journal, Vol. 159, Núm. 6

  2. A singular skin burn

    PACE - Pacing and Clinical Electrophysiology

  3. SmartDelay determined AV optimization: A comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): Rationale and design

    PACE - Pacing and Clinical Electrophysiology, Vol. 33, Núm. 1, pp. 54-63

2009

  1. Morphology discrimination criterion wavelet improves rhythm discrimination in single-chamber implantable cardioverter-defibrillators: Spanish register of morphology discrimination criterion wavelet (REMEDIO)

    Europace, Vol. 11, Núm. 6, pp. 727-733